Sima Lev reccomends: Regulation of the epithelial control gene p63 by oncogenes and the Hippo signaling pathway
MOROSS – Integrated Cancer Center (MICC) cellpress https://weizmann.zoom.us/j/5065402023?pwd=a3Z6KzRCU0xJaUFoM2Y5emZwZm1oZz09
Articles by Prof. Sima Lev
Sima lev recommend: PYK2, a hub of signaling networks in breast cancer progression
Trends In Cell Biology cellpress https://authors.elsevier.com/a/1hb3t3QxxSr7Kn
Sima lev recommend: Early-Stage Triple-Negative Breast Cancer: Optimizing Therapy
Breast Cancer: Optimizing Therapy THE ASCO POST Continue
Sima lev recommend: Updates in Triple-Negative Breast Cancer Treatment
Oncology Nursing News, February 2023 Oncology nurses provide perspective on the changing standards of care for patients with triple-negative breast cancer. Continue
Sima Lev’s lab – Combination Therapy & Drug Resistance
Combination Therapy & Drug Resistance TNBC – Triple-Negative Breast Cancer – accounts for approximately 20 percent of all breast cancer patients and can be divided […]
Treatment advances in metastatic triple-negative breast cancer (TNBC): Addressing the knowledge gap
As of February 2, 2022, 632 clinicians had completed the activity for credit. Baseline assessment data revealed gaps in knowledge regarding emerging actionable targets and […]
Researchers identify regulator of breast cancer development
Researchers identified a causative signaling pathway in breast cancer, providing potential new targets for treatment of the most common type of cancer in women. The findings […]
Accelerating AXL targeting for TNBC therapy Lohit Khera, Sima Lev
First described by electron microscopists in the early 60s the ER-Golgi contact sites in mammalian cells have remained The tyrosine kinase receptor AXL of the […]
The Golgi Apparatus and Membrane Contact Sites
First described by electron microscopists in the early 60s the ER-Golgi contact sites in mammalian cells have remained unexplored for forty years when the discovery […]
